Volume 26, Issue 117 (9-2018)                   J Adv Med Biomed Res 2018, 26(117): 57-73 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Dadashi M, Taremian F, Momtazi S, Khani M, Eskandari Z, Armani Kian A et al . Comparing the Effectiveness of Metacognitive Therapy (MCT), Pharmacotherapy (SSRIs) and EEG Biofeedback in Generalized Anxiety Disorders. J Adv Med Biomed Res 2018; 26 (117) :57-73
URL: http://journal.zums.ac.ir/article-1-5406-en.html
Comparing the Effectiveness of Metacognitive Therapy (MCT), Pharmacotherapy (SSRIs) and EEG Biofeedback in Generalized Anxiety Disorders
Mohsen Dadashi1 , Farhad Taremian2 , Saeid Momtazi3 , Mahdi Khani1 , Zakaria Eskandari1 , Alireza Armani Kian3 , Behrouz Birashk *4
1- Dept. of Clinical Psychology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
2- Dept.of Clinical Psychology, Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
3- Dept. of Psychiatry, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
4- Dept. of Clinical Psychology, Faculty of Behavioral Sciences and Mental Health, Iran University of Medical Sciences, Tehran, Iran
Abstract:   (156725 Views)

Background and Objective: Generalized Anxiety Disorder (GAD) is one of the most common psychological disorders characterized by excessive and uncontrollable worry and it has ahigh comorbidity with other anxiety disorders and depression. The aim of this study was to compare the efficacy of metacognitive therapy (MCT), pharmacotherapy and neurofeedback treatment in treating Iranian patients with GAD.
Methods and Materials: 42 outpatients meeting DSM-5 criteria for GAD who had been referred to Sohravardi clinical psychology and psychiatry center in the city of  Zanjan were chosen on the basis of convenient sampling and were randomly assigned into three treatment groups: metacognitive therapy (n=14), pharmacotherapy (n=14) and neurofeedback treatment (n=14). All patients in each group were treated for 8 weeks. The General Anxiety Disorder Scale (GAD-7) was administered blindly Pre and Post intervention.Alpha brain waves in the occipital area (O1 and O2) using neurofeedback (pro-comp-5) were registered Pretest and Posttest. Throughout the research, 36 patients remained in the study while 6 patients forfeited. The results were analyzed using ANCOVA, ANOVA, Kolmogorov–Smirnov test, ANOVA with repeated measures and post hoc test.
Results: The ANCOVA and post hoc results showed that neurofeedback, MCT and pharmacotherapy led to significant improvements in GAD-7. Also regarding alpha amplitude enhancement, the results indicated that neurofeedback led to a more significant increase when compared to MCT and pharmacotherapy.
Conclusion: It seems that neurofeedback is more effective than MCT and pharmacotherapy for the treatment of GAD and the results of this study confirm the effectiveness of O1-O2 protocol (alpha brain wave amplitude increase) in GAD symptoms severity improvement.

Keywords: General Anxiety Disorder, Metacognitive therapy, Pharmacotherapy, Neurofeedback
Full-Text [PDF 818 kb]   (156598 Downloads)    
Type of Study: Original Research Article |
Received: 2018/11/11 | Accepted: 2018/11/11 | Published: 2018/11/11
References
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders DSM-5. Washington DC London, and England: Author; 2013. [DOI:10.1176/appi.books.9780890425596]
2. Noorbala A, Bagheri M, Yazdi E. The validation of general health questionnaire-28 as a psychiatric screening tool. Hakim J. 1999. 11:47-53.
3. Omidi E, Tabatabaei A, Sazvar S, Akashe G. Epidemiology of mental disorders in Urbanized areas of Natanz.Iran J Psychiat Clin Psychol. 2003; 8: 32-8.
4. Boschen MJ. Publication Trends in Individual Anxiety Disorders: 1980-2015. J Anxiety Disord. 2008; 3: 570-5. [DOI:10.1016/j.janxdis.2007.04.004] [PMID]
5. Cuijpers P, Sijbrandij M, Koole S, Huibers M, Berking, M, Andersson G. Psychological treatment of generalized anxiety disorder: A meta-analysis. Clinical Psychology Review. 2014; 34: 130-40. [DOI:10.1016/j.cpr.2014.01.002] [PMID]
6. Naeinian M, Shoeiri M , Sharifi M, Hadian M. Comparing the effectivnes of neurofeedback and pharmacotherapy in generalized anxiety disorders.Clinical Psy Personal. 2013; 7: 31-42.
7. Tyrer P. Anxiety: a multidisciplinary review, Imperial College Press, London: 1999. [DOI:10.1142/p062]
8. Hammond D. Neurofeedback treatment of depression and anxiety. J Adult Develop. 2005; 12: 131-7 [DOI:10.1007/s10804-005-7029-5]
9. Wells A. Meta-cognition and worry: A cognitive model of generalized anxiety disorder. Behav Cog Psychother. 1995; 23: 301-20. [DOI:10.1017/S1352465800015897]
10. Akbari M. Comparison the efficacy of dugas cognitive therapy in patients with generalized anxiety disorder with MCT. MA thesis in clinical psychology. University of Medical Sciences, Tehran Psychiatric Institute. 2009. [in Persian]
11. Hosseini Ghaffari F. The efficacy of metacognitive therapy in worry patients with generalized anxiety disorder. J Nursing and Midwifery. 2013; 1: 11-20.
12. Shafiee Sang Atash S. The efficacy of metacognitive therapy on anxiety and and metacognitive components of generalized anxiety disorder. J Clin Psychiat. 2013; 4: 19-30.
13. Watson CG, Herder J, Passini FT. Aplha biofeedback therapy in alcoholics: An 18-month follow-up. J Clin Psychol. 1978; 34: 765-69. https://doi.org/10.1002/1097-4679(197807)34:3<765::AID-JCLP2270340339>3.0.CO;2-5 [DOI:10.1002/1097-4679(197807)34:33.0.CO;2-5]
14. Rice KM, Blanchard EB, Purcell M. Biofeedback treatments of generalized anxiety disorder: Preliminary Results. Biofeedback and Self-Regulation. 1993; 18:93-105. [DOI:10.1007/BF01848110] [PMID]
15. Moore N. A review of EEG biofeedback treatment of anxiety disorders. Clin Electroencephalography. 2000; 31: 1-6. [DOI:10.1177/155005940003100105] [PMID]
16. Gosselin P, Ladouceur R, Charkles M,Morin A, Dugas MJ, Baillargeon L. Benzodiazepine discontinuation among adults with GAD: A randomized trial of cognitive- behavioral therapy.J Consult Clin Psychol. 2006; 74: 908-19. [DOI:10.1037/0022-006X.74.5.908] [PMID]
17. Demos N John. Getting started with neurofeedback. W.W. Norton & Company. New York. 2004
18. Passini F T, Watson C, Dehnel L, Herder J, Watkins B. Alpha wave biofeedback training therapy in alcoholics. J Clin Psychol. 1977; 33: 292-99 https://doi.org/10.1002/1097-4679(197701)33:1+<292::AID-JCLP2270330166>3.0.CO;2-L [DOI:10.1002/1097-4679(197701)33:1+3.0.CO;2-L]
19. Naeinian M, Shoeiri M, Sharifi M,Hadian M. To study reliability and validity for a brief measure for assessing generalized anxiety disorder.Clin Psychol Personal. 2011; 2: 41-50.
20. Spitzer RL, Williams JBW, Gibbon M, First M. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry, 1992; 49: 624-29. [DOI:10.1001/archpsyc.1992.01820080032005] [PMID]
21. Amini H, Sharifi H, Mohammadi M, et al. Reliability and feasibility of the Persian version of the structured diagnostic interview for DSM -IV (SCID),Clin Psychol. 2004; 6: 10-22.
22. Janeck AS, Calamari JE, Riemann BC, Heffelfinger SK. Too much thinking about thinking? Metacognitive differences in obsessive-compulsive disorder. J Anxi Disor. 2003; 17:181-95. [DOI:10.1016/S0887-6185(02)00198-6]
23. Sadock BJ, Sadock VA. Kaplan and Sadock's Synopsis of Psychiatry. 9th ed. New York: Williams & Wilkins; 2003.
24. Khorramdel K, Neshatdoost HT, Molavi H, Amiri SH, Bahrami F. The effect of metacognitive therapy of wells in patient with anxiety. J Fundamental Health. 2010;12:400-9.
25. Gharaee B. Consideration some of cognitive and metacognitive models in patients with anxiety and depression. (Dissertation). Tehran: Tehran Psychiatric Institute; 2014.
26. Wells A, King P. Meta cognitive therapy for generalized anxiety disorder: An open trial. J Behav Ther Exp Psychiat. 2006; 37: 206-12. [DOI:10.1016/j.jbtep.2005.07.002] [PMID]
27. Vanathy S, Sharma PSVN, Kumar KB. The efficacy of Alpha and Theta Neurofeedback training in treatment of generalized anxiety disorder. Indian J Clin Psychol. 1998;25:136-43.
28. Hardt JV, Kamiya J. Anxiety change through electroencephalographic alpha feedback seen only in high anxiety subjects. Science. 1978; 201:79-81. [DOI:10.1126/science.663641] [PMID]
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb